This protocol covers mild to moderate plaque psoriasis of the scalp in patients aged 12 years and older. The structured regimen is validated specifically for this age group and anatomical presentation.
The recommended first-line approach for this population involves a fixed-dose combination topical suspension applied to the scalp. The complete protocol specifies the agents, application schedule, treatment duration, and any relevant safety considerations.
DOI: 10.1016/j.jaad.2019.08.049
The combination of calcipotriol/betamethasone dipropionate suspension applied once daily for up to 8 weeks at a time is recommended as a safe and effective treatment for children ages 12 years and older with mild to moderate plaque psoriasis of the scalp.